Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/04/25
This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.Barrons • 11/04/25
Zoetis trims annual revenue forecast on muted demand for animal treatments, shares slideReuters • 11/04/25
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026Business Wire • 11/03/25
Zoetis: High-Quality Compounder For Patient Long-Term Dividend Growth InvestorsSeeking Alpha • 11/03/25
Seeking Clues to Zoetis (ZTS) Q3 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 10/30/25
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in CatsBusiness Wire • 10/29/25
Zoetis (ZTS) Ascends But Remains Behind Market: Some Facts to NoteZacks Investment Research • 10/27/25
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in DogsBusiness Wire • 10/15/25
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA PainZacks Investment Research • 10/13/25
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in DogsBusiness Wire • 10/10/25